ORBIMED ADVISORS LLC – Keros Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$63.18M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+36.16%
quarter
Keros Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 16.77M | $37.62 | 1.67M | |
| Q2 2022 | share | 0.00% | 0 shares | -44.92M | $27.63 | 1.67M | |
| Q1 2022 | share | 0.00% | 0 shares | -6.93M | $54.38 | 1.67M | |
| Q4 2021 | share | 0.00% | 0 shares | 31.82M | $56.3 | 1.67M | |
| Q3 2021 | share | 0.00% | 0 shares | -4.88M | $39.56 | 1.67M | |
| Q2 2021 | share | 0.00% | 0 shares | -32.04M | $42.47 | 1.67M | |
| Q1 2021 | share | 0.00% | 0 shares | -15.09M | $61.55 | 1.67M | |
| Q4 2020 | share | 0.00% | 0 shares | 53.69M | $70.54 | 1.67M | |
| Q3 2020 | share | 0.00% | 0 shares | 1.78M | $38.57 | 1.67M | |
| Q2 2020 | share | Increase | 0.00% | 1.67M shares | 62.99M | $37.51 | 1.67M |